Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license
Fierce Pharma
FEBRUARY 24, 2023
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18
Fierce Pharma
FEBRUARY 24, 2023
Moderna pays US government $400M 'catch-up payment' under new COVID-19 vaccine license esagonowsky Fri, 02/24/2023 - 09:18
Fierce Pharma
FEBRUARY 7, 2023
Vertex pricing under fire—again—as activists press 4 governments for Trikafta generics fkansteiner Tue, 02/07/2023 - 10:08
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 3, 2022
Moderna can't hide behind the government in patent infringement suit, judge rules. zbecker. Thu, 11/03/2022 - 15:47
PharmExec
JANUARY 18, 2023
Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.
Fierce Pharma
OCTOBER 10, 2022
CSL Seqirus scores $30M government contract to produce and test avian flu vaccine candidate. zbecker. Mon, 10/10/2022 - 09:58
PharmExec
FEBRUARY 9, 2023
Examining efforts to boost women representation on company boards.
PharmaTimes
JANUARY 30, 2023
Lilly is calling for Government to freeze the statutory scheme repayment rate for 2023
European Pharmaceutical Review
MARCH 3, 2023
The UK government has confirmed its plans to go ahead with the intended Statutory Scheme rate rise. Through the schemes, the government intends that medicines are supplied at an affordable price both in the life sciences sector and the broader economy.
pharmaphorum
JUNE 30, 2022
billion supply contract with the US government for COVID-19 vaccines, covering 105 million doses that may include Omicron-targeted shots. paid by the federal government for supplies of Comirnaty. The post Pfizer claims new $3.2bn COVID jab deal with US government appeared first on.
PharmaTimes
JULY 19, 2022
Imvanex is a non-replicating smallpox vaccine developed in collaboration with the US government
Copyright Clearance Center
MARCH 9, 2023
The post Topics in Data Management Part II: The Need for Data Governance appeared first on Copyright Clearance Center. CCC in the News
pharmaphorum
AUGUST 31, 2022
In a blog post , assistant secretary for preparedness and response Dawn O’Connell writes that the federal government has “always intended to transition this work to the commercial market and have been planning for that transition.”
Elsevier
MAY 24, 2022
But national, state and city governments also have a critical role in reducing emissions created by various sectors under their jurisdiction. Governments addressing climate action.
World of DTC Marketing
JUNE 5, 2021
The post Obesity represents a catastrophic failure of government policy, public health, and medicine. SUMMARY: Obesity has many causes, and while we would like to think the answer is as easy as people exercising more and eating less, it isn’t that simple.
Pharmaceutical Technology
NOVEMBER 28, 2022
The UK Government has announced funds worth $24.17m (£20m) to conduct research for developing new obesity therapies and technologies. The post UK Government to fund research into new obesity treatments appeared first on Pharmaceutical Technology.
Pharmaceutical Technology
AUGUST 1, 2022
Before the Covid-19 pandemic, government-led investment and engagement in life sciences was relatively restricted worldwide, with the industry mostly funded via private investment. The pandemic forced governments to acknowledge that this status quo had to change.
PharmaTimes
OCTOBER 10, 2022
Partnership will evaluate AI-powered technology in lung cancer care
pharmaphorum
JULY 27, 2022
Latest UK Life Sciences Competitive Indicators “ought to ring alarm bells across Government,” says ABPI. They go on to say that the data are a crucial tool in the delivery of the Government’s commitments to the life sciences sector.
Pharmaceutical Technology
JANUARY 30, 2023
The UK government’s decision to set an unprecedented payback rate of 26.5% Full details of the government’s 2023 VPAS payment calculation may be accessed on the UK Department of Health and Social Care (DHSC) page here.
PharmaTimes
OCTOBER 12, 2022
DIT to showcase Liverpool city region’s life sciences expertise which will also include manufacturing
PharmaTimes
JANUARY 6, 2023
Collaboration will focus on providing up to 10,000 patients with personalised mRNA by 2030
PharmaTimes
AUGUST 19, 2022
Senior public health figures take unusual step of warning government about energy costs
Salesforce
MARCH 2, 2022
The problems afflicting the health industry are especially prevalent in government systems, which are slowed by political gridlock, budget constraints, and inertia. Case study: How Ireland’s government healthcare quickly prepared for COVID-19. government healthcare system.
MedCity News
AUGUST 24, 2022
Following litigation battles and multiple iterations of the Act, the final rules address the arbitration process for insurers and provide more transparency for patients. Daily Legal SYN Top Story Center for Medicare and Medicaid Services Department of Health and Human Services Department of Labor
PharmaTech
NOVEMBER 2, 2022
The DGA seeks to increase trust in data sharing, strengthen mechanisms to make data more available, and overcome obstacles to the reuse of data, which are vital ingredients to the intersectoral use of health data.
Scott’s Directories
AUGUST 9, 2022
The process of making sales to government-run hospitals is quite different from that of making sales to private hospitals. Since government-run hospitals work for the greater good of the entire community, a few crucial factors need to be considered.
PharmExec
DECEMBER 22, 2022
The Consolidated Appropriations Act for 2023 includes dozens of measures involving drug development and regulation.
pharmaphorum
AUGUST 1, 2022
HHS’ latest announcement ends speculation that the US government may be planning a summer booster campaign using the currently-licensed COVID-19 vaccines in order to get ahead of a predicted spike in infections and hospitalisations in the autumn and winter.
Pharmaceutical Technology
JUNE 30, 2022
Pfizer and BioNTech have entered a new vaccine supply agreement worth $3.2bn with the US government to supply further doses of their Covid-19 vaccine. As per the agreement, the government will procure 105 million 3µg, 10 µg and 30 µg doses of the vaccine.
MedCity News
FEBRUARY 12, 2023
Instead of pushing data out into the world, it’s possible to invite selected partners into trusted data environments where they can safely harness your data — without ever directly viewing your datasets.
PharmExec
SEPTEMBER 22, 2022
Thursday, September 22, 2022 at 11am EDT | 8am PDT | 4pm BST |5pm CEST.
MedCity News
OCTOBER 5, 2022
After a key witness arrived at Holmes’ house in August and expressed regrets about his role in the trial, a California judge has decided to grant Holmes a chance for a new trial. Daily Legal SYN Top Story biopharma nl Elizabeth Holmes Theranos
PharmaTech
DECEMBER 22, 2022
The Consolidated Appropriations Act for 2023 provides FDA with a $6.6 billion total budget.
Pharma Leaders
SEPTEMBER 22, 2022
Thursday, September 22, 2022 at 11am EDT | 8am PDT | 4pm BST |5pm CEST. Compliance Channel Posts
Pharmaceutical Commerce
AUGUST 1, 2022
Price tag for bivalent dose was $1.74 billion.
World of DTC Marketing
DECEMBER 30, 2020
Government misses “Warp-speed” vaccinations by 98 million. This is another huge failure of our government. The post Once again our government has failed us appeared first on World of DTC Marketing.com.
Pharmaceutical Technology
JUNE 23, 2022
The post Non-stop investment from CMOs and US Government into continuous manufacturing appeared first on Pharmaceutical Technology.
Pharma Leaders
AUGUST 9, 2022
The investigational drug can be prescribed by doctors for monkeypox patients using the FDA’s expanded access program. Compliance Channel Posts
Clarivate
MARCH 20, 2023
Academia and Government Academic ISI JCR publishing ResearchWe have the important responsibility of providing our customers with trustworthy intelligence to help them transform the world for the better.
Pharmacy Times
AUGUST 29, 2022
Catherine Oakar, special assistant to the President for Public Health and Disparities in the Domestic Policy Council at The White House, discusses plans to address diet-related diseases in a conference held at The White House in September 2022.
Let's personalize your content